MY134868A - Improved growth stimulant compositions - Google Patents

Improved growth stimulant compositions

Info

Publication number
MY134868A
MY134868A MYPI99004773A MYPI9904773A MY134868A MY 134868 A MY134868 A MY 134868A MY PI99004773 A MYPI99004773 A MY PI99004773A MY PI9904773 A MYPI9904773 A MY PI9904773A MY 134868 A MY134868 A MY 134868A
Authority
MY
Malaysia
Prior art keywords
growth stimulant
improved growth
release
improved
stimulant compositions
Prior art date
Application number
MYPI99004773A
Inventor
Shih Chung
Thomas J Kennedy
Knight Peter James
Daniel S Robins
Shao Zezhi Jesse
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of MY134868A publication Critical patent/MY134868A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204Polyesters, e.g. poly(lactide-co-glycolide)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

AN IMPROVED WEIGHT AND GROWTH STIMULANT FOR DOMESTICATED ANIMALS SUCH AS CATTLE, PIGS AND SHEEP IS COMPRISED OF AN ANABOLIC AGENT THAT IS SUBCUTANEOUSLY ADMINISTERED IN THE FORM OF A DUAL RELEASE IMPLANT FORMULATION. INCREASED GAINS ARE PARTICULALRY IMPROVED WHEN ZERANOL IS ADMINISTERED IN AN IMMEDIATE-RELEASE AND CONTROLLED-RELEASE FORMULATION WHICH ALLOWS FOR A ONETIME DOSAGE INJECTION.
MYPI99004773A 1998-11-04 1999-11-03 Improved growth stimulant compositions MY134868A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18594498A 1998-11-04 1998-11-04

Publications (1)

Publication Number Publication Date
MY134868A true MY134868A (en) 2007-12-31

Family

ID=22683037

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI99004773A MY134868A (en) 1998-11-04 1999-11-03 Improved growth stimulant compositions

Country Status (11)

Country Link
AR (1) AR025133A1 (en)
AU (1) AU777393B2 (en)
BR (2) BRPI9914996B8 (en)
CA (1) CA2348841C (en)
CO (1) CO5140100A1 (en)
CR (1) CR6351A (en)
MY (1) MY134868A (en)
PE (1) PE20001092A1 (en)
TW (1) TWI250027B (en)
WO (1) WO2000025743A2 (en)
ZA (1) ZA200103494B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020131988A1 (en) * 1999-12-16 2002-09-19 Foster Todd P. Pharmaceutical implant containing immediate-release and sustained-release components and method of administration
US6953586B1 (en) * 2000-06-08 2005-10-11 Ivy Animal Health, Inc. Growth promoting pharmaceutical implant
EP4000688B1 (en) 2020-11-19 2025-11-05 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Process for the preparation of trenbolone acetate having a definite particle size distribution
EP4001289B1 (en) 2020-11-19 2023-05-03 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Improved process for the preparation of trenbolone and/or trenbolone acetate
EP4001288B1 (en) 2020-11-19 2025-05-07 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Process for the preparation of trenbolone acetate having a definite particle size distribution and a irregular hexagon plates crystal habit

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2573307B1 (en) * 1984-11-22 1988-06-10 Virbac Ctre Rech Biolog EXTENDED RELEASE ANABOLIZING IMPLANTS
US4670249A (en) * 1985-04-12 1987-06-02 International Minerals & Chemical Corp. Growth-promoting compositions
US5219572A (en) * 1989-03-17 1993-06-15 Pitman-Moore, Inc. Controlled release delivery device for macromolecular proteins
US5747060A (en) * 1996-03-26 1998-05-05 Euro-Celtique, S.A. Prolonged local anesthesia with colchicine
US5874098A (en) * 1997-05-28 1999-02-23 Ivy Laboratories, Inc. Pellet implant system

Also Published As

Publication number Publication date
AU3096700A (en) 2000-05-22
CO5140100A1 (en) 2002-03-22
AU777393B2 (en) 2004-10-14
BRPI9914996A (en) 2001-07-10
PE20001092A1 (en) 2000-10-31
BR9914996A (en) 2001-07-10
AR025133A1 (en) 2002-11-13
WO2000025743A2 (en) 2000-05-11
TWI250027B (en) 2006-03-01
CA2348841C (en) 2007-04-17
BRPI9914996B1 (en) 2011-11-01
WO2000025743A3 (en) 2000-08-24
ZA200103494B (en) 2002-07-30
BRPI9914996B8 (en) 2021-07-06
CR6351A (en) 2003-11-20
CA2348841A1 (en) 2000-05-11

Similar Documents

Publication Publication Date Title
BR0008590A (en) Polymeric delivery agent, composition, unit dosage form, method for administering a biologically active agent to an animal requiring the agent, method for preparing a composition; it's composed
NZ524138A (en) Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents
DK0862416T3 (en) Non-polymeric delayed release administration system
BR0013116B1 (en) Single dose oral formulations to control ectoparasite infestation in pets, and their use.
BR0014383A (en) Controlled release compositions comprising nimesulide
EE9900288A (en) Use of an Oral Pharmaceutical Composition for the manufacture of a medicament for the treatment of erectile dysfunction in men
EP0609345A1 (en) Biocompatible implant for the timing of ovulation in mares
MY113488A (en) Compounds with growth hormone releasing properties
SE0002754D0 (en) New pharmaceutical combination formulation and method of treatment with the combination
ATE396967T1 (en) (5-(2-HYDROXY-4-CHLOROBENZOYL)VALERIC ACID AND SALTS THEREOF, AND COMPOSITIONS FOR DELIVERING ACTIVE INGREDIENTS CONTAINING THESE COMPOUNDS
NZ514323A (en) A immunostimulant containing an acitive agent and an adjuvant which increases the effect of the active agent
JP2010500975A (en) Application of initial amount of LHRH analogue and maintenance amount of LHRH antagonist for treatment of hormone-dependent cancer and corresponding pharmaceutical kit
DE69819145D1 (en) BIO-DEGRADABLE MICROPARTICLES WITH DELAYED ACTIVE SUBSTANCE RELEASE
MY134868A (en) Improved growth stimulant compositions
BR9106676A (en) PEPTIDE, PROCESS TO PROMOTE THE RELEASE OF GROWTH HORMONE LEVELS IN ANIMAL, PHARMACEUTICAL COMPOSITION TO PROMOTE THE RELEASE OF GROWTH HORMONE LEVELS IN ANIMALS, USE OF THE COMPOUND AND PROCESS TO PROMOTE THE LIBERATION IN THE ELEVATION BLOOD
US20010041697A1 (en) Implant composition containing melengestrol acetate and trenbolone acetate
EP0236002A3 (en) Pharmaceutical composition comprising a medicament and a water-swellable polymer
RU96103819A (en) FODDER ADDITIVE FOR YOUNG CATTLE
YU14700A (en) 8a-azalides as veterinary antimicrobial agents
TH48412A3 (en) Growth stimulant composition That has been updated
ECSP993205A (en) IMPROVED GROWTH STIMULATING COMPOSITIONS (CASE AHO948)
UA85060C2 (en) Bioactive supplement preparation
UY24399A1 (en) ORAL VETERINARY COMPOSITION CONTAINING AN ANTIBACTERIAL AGENT FLUORQUINOLONO POSSESSING SUPERIOR ABSORBING PROPERTIES AND EXTENDED DURATION OF ANTIMICROBIAL THERAPEUTIC BLOOD LEVELS, AND A METHOD FOR TREATING MICROBIAL INFECTIONS
TH67253A (en) Dosage of metronomic taxane
BR9612813A (en) Antibacterial composition of oral veterinary fluoroquinolone for prolonged duration of therapy and method of treatment